Medications

Inhalation drug may prevent severe pneumonia

Overly active immune cells are often behind lung damage in diseases such as COVID-19. Researchers at the Technical University of Munich (TUM) have developed an RNA agent for a lung spray that slows the activity of these cells, ...

Medications

Novel drug could treat long COVID and prevent re-infection

A new drug developed by QIMR Berghofer could transform the treatment of COVID-19 by potentially protecting against infection by any SARS-CoV-2 variant and reversing the persistent inflammation that is a major driver of debilitating ...

Medical research

Scientists deliver siRNA therapy to lung

Scientists at UMass Chan Medical School have developed a technology to deliver gene therapy directly to lung tissue through intranasal administration, a development that could potentially create a new class of treatments ...

page 4 from 40